NADAC acquisition cost data for AMOX-CLAV 400-57 MG/5 ML SUSP. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00093227973 | $0.0630 | 2022-12-21 | Rx |
| 00143998201 | $0.0630 | 2022-12-21 | Rx |
| 00781610446 | $0.0630 | 2022-12-21 | Rx |
| 16714029303 | $0.0630 | 2022-12-21 | Rx |
| 42571016447 | $0.0630 | 2022-12-21 | Rx |
| 65862053401 | $0.0630 | 2022-12-21 | Rx |
| 00143998275 | $0.0753 | 2022-12-21 | Rx |
| 16714029302 | $0.0753 | 2022-12-21 | Rx |
| 65862053475 | $0.0753 | 2022-12-21 | Rx |
| 66685101201 | $0.0753 | 2022-12-21 | Rx |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.